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Objectives 
• Define lymphedema 
• Explain current evidence based treatment interventions to 
manage the symptoms of lymphedema 
• Explore current access issues to appropriate treatment 
interventions 
• Discuss development and implementation of a lymphedema 
program in a rural healthcare setting including a post-
mastectomy component 
• Discuss development of an educational program for Haitian 
healthcare workers to work towards eradication of lymphatic 
filariasis 
 
What is lymphedema? 
• Lymphedema is characterized by the “accumulation of 
protein-rich fluid within the interstitial spaces, often leading to 
the chronic inflammation and reactive fibrosis in the affected 
tissues” (Foldi, Foldi, & Kubik, 2003, p. 53).  
• Lymphedema can be located in one or multiple extremities, 
the trunk, abdomen, head and neck, external genitalia, and 
internal organs (Zuther & Norton, 2013).  
 
Incidence Rates 
• Lymphedema affects at least 3 million Americans (Quirion, 
2010; Zuther & Norton, 2013) 
• Estimated that more than 11.4 million cancer survivors in the 
United States are at risk for developing this serious condition 
(Armer et al., 2012) 
• Among 120 million people in 83 countries that are infected 
with lymphatic filariasis, up to 16 million have lymphedema 
(Shenoy, 2008).  


Primary vs. Secondary Lymphema 
Primary 
• Occurs due to a 
developmental 
abnormality of the 
lymphatic system that may 
be present at birth or 
develop later in life (Zuther 
& Norton, 2013).  
Secondary 
• Caused by surgery and 
radiation, trauma, 
infection, malignant tumor, 
immobility, and chronic 
venous insufficiency 
(Zuther & Norton, 2013). 
•  May occur immediately 
postoperative, within a few 
months, a couple of years, 
or even 20 years or more 
following surgery 
Stages 
• Stage 0 is known as subclinical or pre-lymphedema, can last 
for a long time, and typically includes all patients who have 
had lymph node dissection. During this stage there is no 
swelling present, however lymph flow is impaired.  
• Stage I is characterized by accumulation of fluid and protein in 
the tissue in which pitting may be present. Elevation may 
reduce the swelling in this stage.  
• Stage II includes swelling that does not reduce with elevation 
and pitting occurs with fibrosis.  
• Stage III is characterized by fibrotic tissue that has 
indiscernible pitting, skin thickening, and large limb volume 
known as elephantiasis (International Society of Lymphology, 
2003).  
Treatment 
• No cure 
• Complete Decongestive Therapy (CDT)  
• Two phases 
1. Intensive Phase 
2. Self-management Phase 
 
Complete Decongestive Therapy (CDT) 
• Manual Lymph Drainage 
• Compression Therapy 
• Therapeutic Exercise 
• Skin Care 
Manual Lymph Drainage 
• Goal: Decrease size of affected area 
• Gentle manual treatment technique that increases the activity 
of certain lymph vessels and manually moves interstitial fluid  
• Reroutes lymphatic load around damaged or blocked 
pathways and utilizes undamaged pathways  
• Massage vs. MLD 
Compression Bandaging 
• In order to prevent the 
swelling from coming 
back, it is necessary to 
apply sufficient 
compression to the 
arm or leg. 
•  Intensive phase: 
Application of special 
short-stretch bandages 
to prevent the re-
accumulation of lymph 
fluid. 
 
 
 
 
 
 
Compression Bandaging – Cont.  
• Self-management phase: Once the extremity is decongested, 
the patient wears compression garments during the day.  
 
Therapeutic Exercise 
• A customized exercise program is designed for each patient in 
order to assist in the decongestive process by stimulating the 
lymphatic system (promoting reabsorption).  
Skin Care 
• The skin of individuals with lymphedema is extremely dry and 
susceptible to infections.  
• Goals:  
   - Avoid bacterial and fungal growth  
   - Avoid infections   
    - Supply moisture to the dry skin 
    - Wound care 
 
Access Issues 
Barriers 
• Lack of medical knowledge and expertise in the diagnosis 
and treatment 
• Geographic barriers 
• Focus on secondary care setting 
• Time and cost for certification of therapist 
• Cost of starting lymphedema program 
 
Lymphedema Program Development – Rural Healthcare 
• Purpose: The purpose of this project is to improve access 
to appropriate treatment interventions to those with 
lymphedema in a rural area.  
 
• Goal: The goal of this project is to help improve 
individuals’ overall quality of life, functional abilities, and 
psychological deficits through education and 
implementation of CDT with aims to combat 
lymphedema and improve the lives of those suffering.  
Rural Program Development 
• Literature Review  
• CLT Certification – ACOLS.org 
• Development of Therapist Documentation Materials* 
• Development of Patient Education Materials * 
• Production of Lymphedema Program Environment 
• Hospital Staff Education 
• Public Education/Marketing 
• Post-Mastectomy Program Development 
Post-Mastectomy Program Development 
• In the United States, the most common cause of 
lymphedema develops in the upper extremity following 
axillary node dissection due to breast cancer and 
subsequent surgical intervention.  
 
• The National Surgical Adjuvant Breast and Bowel Project 
(NSABP) B-04 trial documented rates of breast cancer 
related lymphedema (BCRL) of 58.1%, 38.2%, and 49.1% 
for radical mastectomy, total mastectomy with axillary 
radiation, and total mastectomy.  
Post-Mastectomy Program Development 
• Purpose: The purpose of this project is to improve post-
surgical care for those receiving mastectomies in a rural 
hospital setting.   
 
• Goal: The goal of this project is to help improve individuals’ 
overall quality of life, functional abilities, and psychological 
deficits through education and individualized exercise program 
development. A second goal was to educate on lymphedema 
and preventative techniques to reduce incidence of 
development of lymphedema.  
Post-Mastectomy Program Development 
• Literature Review 
• Collaboration with Med Staff and surgical team 
• Development of Patient Education Materials 
• Hospital staff education 
Post-Mastectomy Program 
• Surgical Day: Introduction of therapist to patient as 
inpatient 
• 3 Day P/O: Evaluation, education, and exercise (with HEP 
set up) 
• 7 Day P/O: Exercise advancement 
• 3 Week P/O: Exercise advancement 
• 6 Week P/O: Exercise advancement and discharge if goals 
met 
Post-Mastectomy Program Outcomes 
• 3 Post-Mastectomy Patients have been seen within the 
rehabilitation department; 3/3 came to 100% of therapy 
sessions; 90% goal attainment;  
 
 
• Future Plans:  
    - Continued Collaboration 
    - Marketing Strategies  
Lymphedema in Third World Countries 
• Lymphatic Filariasis 
• Second leading cause of chronic disability worldwide 
• Mosquito transmission 
• Treatment 
Lymphatic Filariasis 
• Barriers – Extreme poverty, quality of environmental 
surroundings, decreased educational levels, lack of 
quality healthcare organizations 
• Global Programme to Eliminate Lymphatic Filariasis 
(GPELF) 
• Mass drug administration 
• Solutions 
 
Lymphedema Teaching Plan for 
Haitian Healthcare Workers  
• Purpose: The purpose of the teaching plan is to improve 
the knowledge of the medical professionals of Haiti 
about lymphatic filariasis with hopes of combating this 
disease and improving the lives of those suffering.  
• Goal: The goal of this project is to help individuals’ 
overall quality of life, functional abilities, and 
psychological deficits through education and intervention 
about lymphedema. Although there is no cure for this 
disease, with appropriate education and supplies, the 
limb or area of swelling can be significantly reduced. 
Lymphedema Teaching Plan  
• Mission of Hope Haiti 
• Development of Educational Materials 
 
 
 
 
Teaching Plan Objectives 
1. “Teach back” of educational handouts 
2. Correct MLD sequence completed following 
demonstration 
3. Correct application of compression bandaging 
following demonstration 
Content Outline 
• Introduction: Purpose of project, overview of content 
• Body: Lymphedema overview, simple 
anatomy/physiology of systems involved, causes, 
treatment interventions, prevention, pharmacological 
interventions, CDT components 
• Hands on Lab: MLD, Compression bandaging, garment 
measuring 
• Conclusion: Compliance to Pharmacological 
interventions and CDT; Promotion of Self-management 
Methods of Instruction/Resources 
• Lymphedema training packet 
• Lecture 
• Hands-on opportunities 
 
Evaluation of learning: Survey 
Fundraising Materials 
• Monetary  
• Compression bandaging materials 
• Garments 
 
 
 


OT and Lymphedema 
Framework 
 
The goal of this project is to help individuals’ overall quality of life, 
functional abilities, and psychological deficits through education and 
intervention about lymphedema. 
 
Biomechanical Approach 
 
Person-Environment-Occupation-Performance (PEOP) 
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